Compelling evidence has reported that p11 levels are reduced in brain tissue from patients diagnosed with MDD [31–33], whereas genetic p11 ablation induces depression-like behavioral traits [33, 36, 65]. This evidence concerns the gene S100A10 and depressive symptom measurement.